AVITA MEDICAL INC (RCEL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RCEL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RCEL | Executive Chairman & Interim Chief Executive Officer | 60 | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
Cary Vance served as Executive Chairman of the Board and was appointed to the position of Interim Chief Executive Officer by the Board on October 16, 2025. Mr. Vance served as President and CEO of XCath, a privately held neurovascular robotics company, having also served as the CEO of OptiScan Biomedical, Myoscience, and Hansen Medical. Prior to his role at Hansen Medical, he served in various global executive leadership roles at Teleflex, Covidien, and GE HealthCare. He supported these companies as they commercialized and transformed markets with their disruptive and game-changing technologies. Mr. Vance is Lean/Six Sigma Black Belt Certified, NACD Certified, and holds both a Bachelor of Arts degree in Economics and an MBA from Marquette University. The Board believes Mr. Vance is qualified to continue to serve as the Executive Chairman of the Board based on his leadership and governance experience, together with his extensive commercial and operational expertise in the healthcare industry.